News Author: Batya Swift Yasgur Publish date: November 24, 2021
Clinicians should be made aware that low-dose treatment with these drugs for insomnia and anxiety “might come at a cost of shortening patients’ lif...
News Author: Batya Swift Yasgur Publish date: July 7, 2021
Ultimately, all the men interviewed for the study sought formal help from a health care provider, but six went through several months of depressive...
News Author: Batya Swift Yasgur Publish date: August 9, 2015
Bypassing the medical hospitalist service and being admitted directly to the surgical service saves patients with suspected adhesive small bowel obstr...
News Author: Batya Swift Yasgur Publish date: July 9, 2015
Key clinical point: An international prognostic index for patients with chronic lymphocytic leukemia may help to inform treatment decisions.
Major...
News Author: Batya Swift Yasgur Publish date: July 8, 2015
Key clinical point: Bleomycin can be eliminated after two cycles of the ABVD chemotherapeutic regimen based on a negative interim PET scan finding...
News Author: Batya Swift Yasgur Publish date: July 8, 2015
Key clinical point: Reducing the dose of cytarabine from 800 mg/m2 to 500 mg/m2 allowed a regimen of rituximab, bendamustine, and cytarabine to be...
News Author: Batya Swift Yasgur Publish date: July 8, 2015
Key clinical point: Survival rates did not significantly differ for autologous versus allogenic stem cell transplant in patients with peripheral T...
News Author: Batya Swift Yasgur Publish date: July 8, 2015
Key clinical point: Rituximab plus bendamustine may prove to be an option for induction therapy prior to autologous stem cell transplant in patien...
News Author: Batya Swift Yasgur Publish date: July 7, 2015
Key clinical point: A second pathological review of newly-diagnosed lymphoma or suspected lymphoma found discrepancies in 17% of cases. Major findi...
News Author: Batya Swift Yasgur Publish date: April 16, 2015
